TrialGynecologic oncology2014

A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group study.

Ronald D Alvarez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.